Shares of Legend Biotech , a cell therapy unit owned by Hong Kong-listed Genscript Biotech , jumped nearly 61% in their stock market debut, signaling strong investor appetite for new listings.

Legend Biotech shares jump nearly 61% in U.S. market debut

Any comments?

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: